A 50-week, placebo-controlled trial shows that combining infliximab and methotrexate provides no extra benefit in treating Crohn’s disease.
References and Resources
Feagan B. A randomized trial of methotrexate in combination with infliximab for the treatment of Crohn’s disease. Digestive Disease Week; 2008: Abstract 682c.
No Benefit with Combined Methotrexate and Infliximab for Crohn’s
May 29, 2008 • Gastroenterology, Gastroenterology: IBD, Hospitalist, Internal Medicine, Preventative Health
